NCT05695872

A Comparison of Three Surgical Approaches to Zygomaticomaxillary Fractures

Completed NA Last updated 9 May 2023

What this trial tests

NA trial testing subtarsal approach in Zygomatic Fractures in 24 participants. Completed in 5 February 2023.

Timeline

26 August 2022

Primary endpoint
1 February 2023

5 February 2023

Quick facts

Lead sponsor	University of Alexandria
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	26 August 2022
Primary completion	1 February 2023
Estimated completion	5 February 2023
Sites	1 location across Egypt

Drugs / interventions tested

• subtarsal approach
• conventional transconjunctival approach
• transconjunctival approach with Y- modification

Conditions studied

• Zygomatic Fractures — all drugs for Zygomatic Fractures →

Sponsor

University of Alexandria

Who can join

Adults 20 to 50, any sex, with Zygomatic Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a randomized controlled clinical trial, following the Consolidated Standards of Reporting Trials (CONSORT) guidelines. The study is intended to compare between the subtarsal approach, conventional transconjuctival approach and the Y- modification of the transconjuctival approach in the management of zygomatico-maxillay complex fracture.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Zygomaticomaxillary complex fractures: finding the least complicated surgical approach (A Randomized Clinical Trial).
   Melek LN, Noureldin MG. · · 2023 · cited 17× · PMID 37542217 · DOI 10.1186/s12903-023-03249-8